+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery & Development, Academic Research), End-user (Biotechnology Companies, CROs), and Region - Forecast to 2026

  • ID: 5281093
  • Report
  • February 2021
  • Region: Global
  • 172 Pages
  • Markets and Markets
Global Recombinant Proteins Market is Projected to Reach USD 1.7 Billion by 2026, Rising at a CAGR of 9.8%

FEATURED COMPANIES

  • Abcam plc
  • Biolegend
  • Cellgenix GmbH
  • Merck KGaA
  • Peprotech, Inc.
  • Proteogenix
  • MORE

The global recombinant proteins market is projected to reach USD 1,705.9 million by 2026 from USD 1,070.9 million in 2021, at a CAGR of 9.8% during the forecast period.

The market growth is primarily driven by factors such as increasing government investments and R&D expenditure in pharmaceutical & biotechnology companies, growing industry academia collaborations, and the patent expiry of biologic products. Emerging markets in Asian countries and the rising focus on personalized medicine & protein therapeutics are other factors expected to offer strong growth opportunities for players in the recombinant proteins market. In contrast, the declining cost of recombinant proteins may restrict market growth to a certain extent.

The pharmaceutical & biopharmaceutical companies segment is expected to dominate the market during the forecast period

Based on end users, the recombinant proteins market is segmented into pharmaceutical & biopharmaceutical companies, biotechnology companies, academic research institutes, contract research organizations, and other end users. Pharmaceutical & biopharmaceutical companies accounted for the largest share of the end-user market in 2020. The large share of this segment is attributed to the high requirement of recombinant proteins for prognostic, predictive, or diagnostic identification and the quantification of biomarkers in drug discovery & development. Moreover, factors such as the patent expiration of blockbuster drugs and increasing investments in drug development support the growth of this segment.

Biologics segment will witness the highest growth in the recombinant proteins market

Based on type, the drug discovery & development market is segmented into biologics, vaccines, and cell & gene therapy. Biologics accounted for the largest share of the drug discovery & development application for the recombinant proteins market and is expected to register the highest CAGR during the forecast period. The large share of the biologics segment is attributed to the factors such as the increasing prevalence & incidence of target diseases, increasing research & development, and the strong development pipeline for recombinant protein-based biologics.

North America will dominate the market during the forecast period

Geographically, the recombinant proteins market is segmented into North America, Europe, the Asia-Pacific, and the Rest of the World. In 2019, North America accounted for the largest share of the recombinant proteins market. The large share of this region in the global market is attributed to the rising incidences of chronic & infectious diseases, increasing R&D spending, increasing research activities, favorable government funding, and the presence of key players in this region.

Research Coverage

This report provides a detailed picture of the global recombinant proteins market. It aims at estimating the size and future growth potential of the market across different segments, such as product, application, end-user and region. The report also analyzes factors (such as drivers, restraints, and opportunities) affecting market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total recombinant proteins market. The report forecasts the revenue of the market segments with respect to four major regions.

List of companies profiled in the report:

  • Thermo Fisher Scientific, Inc. (US)
  • Miltenyi Biotech (Germany)
  • Sino Biological Inc. (China)
  • Merck KGaA (Germany)
  • Abcam plc (UK)
  • Biolegend (US)
  • Bio-Rad Laboratories, Inc. (US)
  • GenScript Biotech Corporation (China)
  • Enzo Life Sciences, Inc. (US)
  • BPS Bioscience, Inc. (US)
  • PeproTech, Inc. (US)
  • Proteintech Group, Inc. (US)
  • Abnova Corporation (Taiwan)
  • R&D Systems (US)
  • STEMCELL Technologies Inc (Canada)
  • RayBiotech Inc (US)
  • CellGenix GmbH (Germany)
  • ACROBiosystems (US)
  • ProSpec-TechnoGene Ltd. (Israel)
  • Neuromics (US)
  • RICHCORE LIFESCIENCES PVT LTD (India)
  • Icosagen AS (US)
  • ProteoGenix (France)
  • United States Biological (US)
  • StressMarq Biosciences Inc (Canada)
  • Aviva Systems Biology Corporation (US)

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 36%, Tier 2 - 45%, and Tier 3 - 19%
  • By Designation: C-level - 33%, D-level - 40%, and Others - 27%
  • By Region: North America - 36%, Europe - 28%, Asia-Pacific - 19%, and RoW - 17%

Reasons to Buy the Report

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on recombinant proteins offered by the top 25 players in the recombinant proteins market. The report analyses the recombinant proteins market by product, application, end-user and region.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various recombinant proteins across key geographic regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the recombinant proteins market.
  • Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the recombinant proteins market.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abcam plc
  • Biolegend
  • Cellgenix GmbH
  • Merck KGaA
  • Peprotech, Inc.
  • Proteogenix
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Inclusion & Exclusions
1.3 Market Scope
Figure 1 Recombinant Proteins Market
1.3.1 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
Figure 2 Research Design
2.2 Secondary Data
2.2.1 Secondary Sources
2.3 Primary Data
2.3.1 Key Data from Primary Sources
Figure 3 Breakdown of Primary Interviews: by Company Type, Designation, and Region
2.4 Market Size Estimation
2.4.1 Bottom-Up Approach
Figure 4 Market Size Estimation: Bottom-Up Approach
2.4.2 Top-Down Approach
Figure 5 Market Size Estimation: Top-Down Approach
2.4.3 Growth Forecast
2.5 Market Breakdown and Data Triangulation
Figure 6 Data Triangulation Methodology
2.6 Assumptions for the Study

3 Executive Summary
Figure 7 Recombinant Proteins Market, by Product, 2021 vs. 2026 (USD Million)
Figure 8 Recombinant Proteins Market, by Application, 2021 vs. 2026 (USD Million)
Figure 9 Recombinant Proteins Market for Drug Discovery & Development Application, by Type, 2021-2026 (USD Million)
Figure 10 Recombinant Proteins Market, by End-user, 2021 vs. 2026 (USD Million)
Figure 11 Geographic Snapshot of the Global Recombinant Proteins Market

4 Premium Insights
4.1 Recombinant Proteins Market Overview
Figure 12 Increasing Government Investments & the Rising Focus on Personalized Medicine to Drive Market Growth During the Forecast Period
4.2 Asia-Pacific: Recombinant Proteins Market, by Application & by Country (2021)
Figure 13 The Drug Discovery & Development Segment is Expected to Account for the Largest Share, by Application, for 2021
4.3 Recombinant Proteins Market, by End-user, 2021-2026
Figure 14 Pharmaceutical & Biopharmaceutical Companies are Expected to be the Largest End-users of Recombinant Proteins During the Forecast Period
4.4 Recombinant Proteins Market: Geographic Snapshot
Figure 15 China to Register the Highest Growth During the Forecast Period

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 16 Recombinant Proteins Market: Drivers, Restraints, and Opportunities
5.2.1 Drivers
5.2.1.1 Rising Government Funding and Increasing R&D Expenditure in Pharmaceutical & Biotechnology Companies
Table 1 Government Funding for Life Science Research (2017-2020)
5.2.1.2 The High Prevalence of Infectious & Chronic Diseases
5.2.1.3 Growing Industry-Academia Collaborations
5.2.1.4 Patent Expiry of Biologics
5.2.2 Restraints
5.2.2.1 The Declining Cost of Recombinant Proteins
5.2.3 Opportunities
5.2.3.1 Emerging Economies
5.2.3.2 Rising Focus on Personalized Medicine and Protein Therapeutics
Table 2 Commercialized Recombinant Proteins Used in Medicine
5.2.3.3 Increasing Focus on Biomarker Discovery
5.2.4 COVID Impact Analysis
5.3 Pricing Analysis
Table 3 Price of Recombinant Proteins (USD)
5.4 Stakeholder Analysis
Figure 17 Recombinant Proteins Market - Stakeholder Analysis
5.5 Value Chain Analysis
Figure 18 Value Chain Analysis: Major Value is Added During the Manufacturing and Assembly Phase
5.6 Recombinant Proteins Forms an Integral Part of Biotechnology
Figure 19 Biotechnology Ecosystem Analysis
5.7 Porter's Five Forces Analysis
Figure 20 Requirement of High Capital Investments to Restrict the Entry of New Players
5.7.1 Threat of New Entrants
5.7.2 Threat of Substitutes
5.7.3 Bargaining Power of Buyers
5.7.4 Bargaining Power of Suppliers
5.7.5 Intensity of Rivalry

6 Recombinant Proteins Market, by Product
6.1 Introduction
Table 4 Recombinant Proteins Market, by Product, 2019-2026 (USD Million)
6.2 Growth Factors and Chemokines
6.2.1 this Segment Accounted for the Largest Share of the Recombinant Proteins Market in 2020
Table 5 Growth Factors and Chemokines Market, by Region, 2019-2026 (USD Million)
6.3 Immune Response Proteins
6.3.1 Immune Checkpoint Proteins Play a Major Role in Cancer Immunotherapy
Table 6 Immune Response Proteins Market, by Region, 2019-2026 (USD Million)
6.4 Structural Proteins
6.4.1 Structural Proteins are Utilized in Cell Culture Applications as Attachment Factors
Table 7 Structural Proteins Market, by Region, 2019-2026 (USD Million)
6.5 Membrane Proteins
6.5.1 Membrane Proteins are Responsible for Regulating Processes That Help Biological Cells Survive
Table 8 Membrane Proteins Market, by Region, 2019-2026 (USD Million)
6.6 Kinase Proteins
6.6.1 Kinase Proteins Play a Major Role in Signal Transduction Pathways
Table 9 Kinase Proteins Market, by Region, 2019-2026 (USD Million)
6.7 Regulatory Proteins
6.7.1 Regulatory Proteins Help Understand Cell Cycle Regulation and Carcinogenesis
Table 10 Regulatory Proteins Market, by Region, 2019-2026 (USD Million)
6.8 Recombinant Metabolic Enzymes
6.8.1 Enzymes Regulate Protein Interactions
Table 11 Recombinant Metabolic Enzymes Market, by Region, 2019-2026 (USD Million)
6.9 Adhesion Molecules and Receptors
6.9.1 Cell Adhesion Molecules Facilitate Extracellular Matrix (ECM) Interactions
Table 12 Adhesion Molecules and Receptors Market, by Region, 2019-2026 (USD Million)
6.10 Other Recombinant Proteins
Table 13 Other Recombinant Proteins Market, by Region, 2019-2026 (USD Million)

7 Recombinant Proteins Market, by Application
7.1 Introduction
Table 14 Recombinant Proteins Market, by Application, 2019-2026 (USD Million)
7.2 Drug Discovery & Development
Table 15 Recombinant Proteins Market for Drug Discovery & Development, by Region, 2019-2026 (USD Million)
Table 16 Recombinant Proteins Market for Drug Discovery & Development, by Type, 2019-2026 (USD Million)
7.2.1 Biologics
7.2.1.1 Biologics are Used to Treat Cancer, Autoimmune Diseases, and Other Serious Disorders
Table 17 Recombinant Protein Biologics Drugs
Table 18 Recombinant Proteins Market for Biologics, by Region, 2019-2026 (USD Million)
7.2.2 Vaccines
7.2.2.1 Rising Incidences of Infectious Diseases to Boost the Market Growth for Vaccines
Table 19 Recombinant Proteins Market for Vaccines, by Region, 2019-2026 (USD Million)
7.2.3 Cell & Gene Therapy
7.2.3.1 Stem Cell Therapy and Cart Therapies Have Increased the Demand for Recombinant Proteins
Table 20 Recombinant Proteins Market for Cell & Gene Therapy, by Region, 2019-2026 (USD Million)
7.3 Academic Research Studies
7.3.1 Recombinant Proteins are Used in Molecular and Gene Expression Studies, Thus Aiding Market Growth
Table 21 Recombinant Proteins Market for Academic Research Studies, by Region, 2019-2026 (USD Million)
7.4 Biopharmaceutical Production
7.4.1 Recombinant Proteins are Widely Used for the Development of Protein-Based Drugs
Table 22 Recombinant Proteins Market for Biopharmaceutical Production, by Region, 2019-2026 (USD Million)
7.5 Biotechnology Research
7.5.1 The Increasing Number of Research Projects in Genomics to Drive Market Growth
Table 23 Recombinant Proteins Market for Biotechnology Research, by Region, 2019-2026 (USD Million)
7.6 Other Applications
Table 24 Recombinant Proteins Market for Other Applications, by Region, 2019-2026 (USD Million)

8 Recombinant Proteins Market, by End-user
8.1 Introduction
Table 25 Recombinant Proteins Market, by End-user, 2019-2026 (USD Million)
8.2 Pharmaceutical & Biopharmaceutical Companies
8.2.1 Pharmaceutical & Biopharmaceutical Companies are the Largest End-User Segment for Recombinant Proteins Used in Target Detection & Drug Discovery
Table 26 Recombinant Proteins Market for Pharmaceutical & Biopharmaceutical Companies, by Region, 2019-2026 (USD Million)
8.3 Biotechnology Companies
8.3.1 Increasing Number of Projects for Protein-Based Research Drives Market Growth
Table 27 Recombinant Proteins Market for Biotechnology Companies, by Region, 2019-2026 (USD Million)
8.4 Academic Research Institutes
8.4.1 Growing Government Investments to Propel Market Growth
Table 28 Recombinant Proteins Market for Academic Research Institutes, by Region, 2019-2026 (USD Million)
8.5 Contract Research Organizations (CROs)
8.5.1 Increasing Outsourcing of Services to CROs Drives Market Growth
Table 29 Recombinant Proteins Market for Contract Research Organizations, by Region, 2019-2026 (USD Million)
8.6 Other End-users
Table 30 Recombinant Proteins Market for Other End-users, by Region, 2019-2026 (USD Million)

9 Recombinant Protein Market, by Region
9.1 Introduction
Table 31 Recombinant Proteins Market, by Region, 2019-2026 (USD Million)
9.2 North America
Figure 21 North America: Recombinant Proteins Market Snapshot
Table 32 North America: Recombinant Proteins Market, by Country, 2019-2026 (USD Million)
Table 33 North America: Recombinant Proteins Market, by Product, 2019-2026 (USD Million)
Table 34 North America: Recombinant Proteins Market, by Application, 2019-2026 (USD Million)
Table 35 North America: Recombinant Proteins Market for Drug Discovery & Development Application, by Type, 2019-2026 (USD Million)
Table 36 North America: Recombinant Proteins Market, by End-user, 2019-2026 (USD Million)
9.2.1 US
9.2.1.1 The US Accounted for the Largest Share of the North American Market for Recombinant Proteins During the Forecast Period
Table 37 US NIH Budget for Various Disciplines, FY 2019 vs. FY 2020 (USD Billion)
Table 38 US: Recombinant Proteins Market, by Product, 2019-2026 (USD Million)
Table 39 US: Recombinant Proteins Market, by Application, 2019-2026 (USD Million)
Table 40 US: Recombinant Proteins Market for Drug Discovery & Development Application, by Type, 2019-2026 (USD Million)
Table 41 US: Recombinant Proteins Market, by End-user, 2019-2026 (USD Million)
9.2.2 Canada
9.2.2.1 The High Prevalence of Cancer and Favorable Funding Scenario in Canada is Expected to Support Market Growth
Table 42 Canada: Recombinant Proteins Market, by Product, 2019-2026 (USD Million)
Table 43 Canada: Recombinant Proteins Market, by Application, 2019-2026 (USD Million)
Table 44 Canada: Recombinant Proteins Market for Drug Discovery & Development Application, by Type, 2019-2026 (USD Million)
Table 45 Canada: Recombinant Proteins Market, by End-user, 2019-2026 (USD Million)
9.3 Europe
Table 46 Europe: Recombinant Proteins Market, by Country, 2019-2026 (USD Million)
Table 47 Europe: Recombinant Proteins Market, by Product, 2019-2026 (USD Million)
Table 48 Europe: Recombinant Proteins Market, by Application, 2019-2026 (USD Million)
Table 49 Europe: Recombinant Proteins Market for Drug Discovery & Development Application, by Type, 2019-2026 (USD Million)
Table 50 Europe: Recombinant Proteins Market, by End-user, 2019-2026 (USD Million)
9.3.1 Germany
9.3.1.1 Germany Held the Largest Share of the Market in Europe in 2020
Table 51 Germany: Recombinant Proteins Market, by Product, 2019-2026 (USD Million)
Table 52 Germany: Recombinant Proteins Market, by Application, 2019-2026 (USD Million)
Table 53 Germany: Recombinant Proteins Market for Drug Discovery & Development Application, by Type, 2019-2026 (USD Million)
Table 54 Germany: Recombinant Proteins Market, by End-user, 2019-2026 (USD Million)
9.3.2 UK
9.3.2.1 Government Initiatives to Drive Market Growth in the UK
Table 55 UK: Recombinant Proteins Market, by Product, 2019-2026 (USD Million)
Table 56 UK: Recombinant Proteins Market, by Application, 2019-2026 (USD Million)
Table 57 UK: Recombinant Proteins Market for Drug Discovery &Development Application, by Type, 2019-2026 (USD Million)
Table 58 UK: Recombinant Proteins Market, by End-user, 2019-2026 (USD Million)
9.3.3 France
9.3.3.1 Infrastructural Development and Rising Life Science R&D Supports Market Growth in France
Table 59 France: Recombinant Proteins Market, by Product, 2019-2026 (USD Million)
Table 60 France: Recombinant Proteins Market, by Application, 2019-2026 (USD Million)
Table 61 France: Recombinant Proteins Market for Drug Discovery & Development Application, by Type, 2019-2026 (USD Million)
Table 62 France: Recombinant Proteins Market, by End-user, 2019-2026 (USD Million)
9.3.4 Italy
9.3.4.1 Life Science Research Investments and a Favorable Funding Scenario are the Key Growth Drivers for Market Growth
Table 63 Italy: Recombinant Proteins Market, by Product, 2019-2026 (USD Million)
Table 64 Italy: Recombinant Proteins Market, by Application, 2019-2026 (USD Million)
Table 65 Italy: Recombinant Proteins Market for Drug Discovery & Development Application, by Type, 2019-2026 (USD Million)
Table 66 Italy: Recombinant Proteins Market, by End-user, 2019-2026 (USD Million)
9.3.5 Spain
9.3.5.1 a Favorable Scenario for Research Initiatives Drives the Market Growth in Spain
Table 67 Spain: Recombinant Proteins Market, by Product, 2019-2026 (USD Million)
Table 68 Spain: Recombinant Proteins Market, by Application, 2019-2026 (USD Million)
Table 69 Spain: Recombinant Proteins Market for Drug Discovery & Development Application, by Type, 2019-2026 (USD Million)
Table 70 Spain: Recombinant Proteins Market, by End-user, 2019-2026 (USD Million)
9.3.6 Rest of Europe (RoE)
Table 71 RoE: Recombinant Proteins Market, by Product, 2019-2026 (USD Million)
Table 72 RoE: Recombinant Proteins Market, by Application, 2019-2026 (USD Million)
Table 73 RoE: Recombinant Proteins Market for Drug Discovery & Development Application, by Type, 2019-2026 (USD Million)
Table 74 RoE: Recombinant Proteins Market, by End-user, 2019-2026 (USD Million)
9.4 Asia-Pacific
Figure 22 Asia-Pacific: Recombinant Proteins Market Snapshot
Table 75 Asia-Pacific: Recombinant Proteins Market, by Country, 2019-2026 (USD Million)
Table 76 Asia-Pacific: Recombinant Proteins Market, by Product, 2019-2026 (USD Million)
Table 77 Asia-Pacific: Recombinant Proteins Market, by Application, 2019-2026 (USD Million)
Table 78 Asia-Pacific: Recombinant Proteins Market for Drug Discovery & Development Application, by Type, 2019-2026 (USD Million)
Table 79 Asia-Pacific: Recombinant Proteins Market, by End-user, 2019-2026 (USD Million)
9.4.1 Japan
9.4.1.1 Advanced Healthcare Infrastructure to Support Market Growth in Japan
Table 80 Japan: Recombinant Proteins Market, by Product, 2019-2026 (USD Million)
Table 81 Japan: Recombinant Proteins Market, by Application, 2019-2026 (USD Million)
Table 82 Japan: Recombinant Proteins Market for Drug Discovery & Development Application, by Type, 2019-2026 (USD Million)
Table 83 Japan: Recombinant Proteins Market, by End-user, 2019-2026 (USD Million)
9.4.2 China
9.4.2.1 China is the Fastest-Growing Segment of the Overall APAC Market During the Forecast Period
Table 84 China: Recombinant Proteins Market, by Product, 2019-2026 (USD Million)
Table 85 China: Recombinant Proteins Market, by Application, 2019-2026 (USD Million)
Table 86 China: Recombinant Proteins Market for Drug Discovery & Development Application, by Type, 2019-2026 (USD Million)
Table 87 China: Recombinant Proteins Market, by End-user, 2019-2026 (USD Million)
9.4.3 India
9.4.3.1 Strong Biopharmaceutical Growth and the Rising Demand for Pharmaceuticals are Key Market Drivers for Growth in India
Table 88 India: Recombinant Proteins Market, by Product, 2019-2026 (USD Million)
Table 89 India: Recombinant Proteins Market, by Application, 2019-2026 (USD Million)
Table 90 India: Recombinant Proteins Market for Drug Discovery & Development Application, by Type, 2019-2026 (USD Million)
Table 91 India: Recombinant Proteins Market, by End-user, 2019-2026 (USD Million)
9.4.4 Rest of Asia-Pacific (RoAPAC)
Table 92 RoAPAC: Recombinant Proteins Market, by Product, 2019-2026 (USD Million)
Table 93 RoAPAC: Recombinant Proteins Market, by Application, 2019-2026 (USD Million)
Table 94 RoAPAC: Recombinant Proteins Market for Drug Discovery & Development Application, by Type, 2019-2026 (USD Million)
Table 95 RoAPAC: Recombinant Proteins Market, by End-user, 2019-2026 (USD Million)
9.5 Rest of the World (RoW)
Table 96 RoW: Recombinant Proteins Market, by Product, 2019-2026 (USD Million)
Table 97 RoW: Recombinant Proteins Market, by Application, 2019-2026 (USD Million)
Table 98 RoW: Recombinant Proteins Market for Drug Discovery & Development Application, by Type, 2019-2026 (USD Million)
Table 99 RoW: Recombinant Proteins Market, by End-user, 2019-2026 (USD Million)

10 Competitive Landscape
10.1 Overview
Figure 23 Key Players Adopted Organic and Inorganic Growth Strategies Between 2018 and 2020
Figure 24 Market Evolution Framework
10.2 Market Share Analysis, 2019
Figure 25 Recombinant Proteins Market, by Key Players, 2019
10.3 Competitive Scenario
10.3.1 Partnerships, Agreements, and Collaborations (2018-2020)
10.3.2 Product Launches & Approvals (2018-2020)
10.3.3 Expansions (2018-2020)
10.3.4 Acquisitions (2018-2020)
10.4 Company Evaluation Quadrant (2020)
10.4.1 Vendor Inclusion Criteria
10.4.2 Stars
10.4.3 Emerging Leaders
10.4.4 Pervasive Players
10.4.5 Participants
Figure 26 Vendor Dive Comparison Matrix: Recombinant Proteins Market

11 Company Profiles
(Business Overview, Products Offered, Recent Developments, Analyst's View)*
11.1 R&D Systems
Figure 27 BioTechne Corporation: Company Snapshot (2019)
11.2 Thermo Fisher Scientific Inc.
Figure 28 Thermo Fisher Scientific Inc.: Company Snapshot (2019)
11.3 Merck KGaA
Figure 29 Merck KGaA: Company Snapshot (2019)
Table 100 Exchange Rates (Used for the Conversion of Euro to USD)
11.4 Abcam plc
Figure 30 Abcam plc: Company Snapshot (2020)
11.5 ABnova Corporation
11.6 Biolegend
11.7 Bio-Rad Laboratories, Inc.
Figure 31 Bio-Rad Laboratories, Inc.: Company Snapshot (2019)
11.8 BPS Bioscience, Inc.
11.9 Enzo Life Sciences, Inc.
Figure 32 Enzo Biochem, Inc.: Company Snapshot (2019)
11.10 Genscript Biotech Corporation
Figure 33 Genscript Biotech Corporation: Company Snapshot (2019)
11.11 Miltenyi Biotech
11.12 Peprotech, Inc.
11.13 Proteintech Group
11.14 Sino Biological Inc.
11.15 Acrobiosystems
11.16 Aviva Systems Biology Corporation
11.17 Cellgenix GmbH
11.18 Icosagen AS
11.19 Neuromics
11.20 Prospec-Technogene Ltd.
11.21 Proteogenix
11.22 Raybiotech, Inc.
11.23 Richcore Lifesciences Pvt. Ltd.
11.24 Stemcell Technologies Inc.
11.25 Stressmarq Biosciences Inc.
11.26 United States Biological
*Business Overview, Products Offered, Recent Developments, Analyst's View Might Not be Captured in Case of Unlisted Companies

12 Appendix
12.1 Discussion Guide
12.2 Knowledge Store: The Subscription Portal
12.3 Available Customization
12.4 Related Report

Note: Product cover images may vary from those shown
  • Abcam plc
  • Abnova Corporation
  • Acrobiosystems
  • Aviva Systems Biology Corporation
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Biolegend
  • BPS Bioscience, Inc.
  • Cellgenix GmbH
  • Enzo Life Sciences, Inc.
  • Genscript Biotech Corporation
  • Icosagen AS
  • Merck KGaA
  • Miltenyi Biotech
  • Neuromics
  • Peprotech, Inc.
  • Prospec-Technogene Ltd.
  • Proteintech Group, Inc.
  • Proteogenix
  • R&D Systems
  • RayBiotech, Inc.
  • Richcore Lifesciences Pvt. Ltd.
  • Sino Biological Inc.
  • STEMCELL Technologies Inc
  • Stressmarq Biosciences Inc.
  • Thermo Fisher Scientific, Inc.
  • United States Biological
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll